EW vs VC · P/E 47, rev $1.39B vs P/E 18, rev $3.87B
Edwards Lifesciences Corp (EW) versus Visteon Corp (VC) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Visteon Corp (VC) is a auto parts company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported VC revenue for 2024-12-31 was $3.87B. Net income was $284.0M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. VC currently screens at market cap $2.95B and trailing P/E 18.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. VC currently screens at market cap $2.95B and trailing P/E 18.5.
Not investment advice. Open the EW and VC stock pages for the full models.
Not investment advice.